CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 259 enrolled
Drug / intervention
Lipid Self Testdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00828945
NCT00828945N/ACompleted

A Non-Randomized, Non-Controlled, Open Study In Order To Document The Compliance With Treatment, According To Clinical Praxis And National Guidelines For Patients With Hyperlipidemia. COLL: Control Of Lipid Lowering

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.·observational·Posted Jan 26, 2009·Updated Feb 21, 2021

In Brief

An observational study evaluating Lipid Self Test for Hyperlipidemia. Completed, enrolled 259 participants across 17 sites.

Detailed Summary

It is a prospective observational study. Patients will be high risk patients (for developing cardiovascular events) that are treated with a statin. Patients will be enrolled at a normal clinic visit and provided with a small box containing info about the disease, a LDL self-test and two questionnaires. They will test themselves for LDL at home between normal clinic visits (normally 12 months interval) and note their value. In the end of the study all patients will fill out a questionnaire with questions if the tests and info have raised their awareness of the disease as well if their motivation to be compliant has increased. We want to look at the possibility to put more responsibility for treatment and for reaching treatment goals on the patients since there's a big problem with compliance in this group of patients.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHyperlipidemia
CountriesSweden
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJan 26, 2009
Enrollment StartFeb 1, 2009
Primary CompletionMar 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 17.4 years ago

Interventions

Lipid Self Testdevice

Self test for lipid levels, twice during study period